The Motley Foolยท2025-08-20 17:32Core Viewpoint - UBS initiated coverage of Oklo stock with a neutral rating and a price target of $65, leading to a nearly 7% drop in shares before a partial recovery [1][3]. Group 1: UBS's Position on Oklo - UBS is "cautiously optimistic" about the potential for a nuclear renaissance in the U.S. due to President Trump's executive orders, which could create a $75 billion market for nuclear power plants and fuel [4]. - Despite this optimism, UBS requires further progress in commercializing Oklo's technology before considering a purchase [4]. - UBS noted that Oklo's stock appears "elevated," suggesting caution regarding its current valuation [5]. Group 2: Oklo's Financial Situation - Oklo currently has no earnings, free cash flow, or revenue, making it difficult to assess its valuation accurately [6]. - Analysts do not expect significant movement in Oklo's stock until 2027, when revenues may begin to materialize, with earnings projected for 2030 at the earliest [6]. - The stock is characterized as speculative, indicating high risk for potential investors [6].